نتایج جستجو برای: boost vaccination

تعداد نتایج: 84560  

Journal: :Vaccine 2010
Stefania Capone Arturo Reyes-Sandoval Mariarosaria Naddeo Loredana Siani Virginia Ammendola Christine S Rollier Alfredo Nicosia Stefano Colloca Riccardo Cortese Antonella Folgori Adrian V S Hill

Malaria is a major health problem as nearly half of the human population is exposed to this parasite causing around 600 million clinical cases annually. Prime-boost regimes using simian adenoviral vectors and MVA expressing the clinically relevant Plasmodium falciparum ME.TRAP antigen have shown outstanding protective efficacy in mouse models. We now extend those observations to macaque monkeys...

2014
Alexandra J. Spencer Matthew G. Cottingham Jennifer A. Jenks Rhea J. Longley Stefania Capone Stefano Colloca Antonella Folgori Riccardo Cortese Alfredo Nicosia Migena Bregu Adrian V. S. Hill

The orthodox role of the invariant chain (CD74; Ii) is in antigen presentation to CD4+ T cells, but enhanced CD8+ T cells responses have been reported after vaccination with vectored viral vaccines encoding a fusion of Ii to the antigen of interest. In this study we assessed whether fusion of the malarial antigen, ME-TRAP, to Ii could increase the vaccine-induced CD8+ T cell response. Following...

Journal: :Journal of immunology 2007
Erik Rollman Miranda Z Smith Andrew G Brooks Damian F J Purcell Bartek Zuber Ian A Ramshaw Stephen J Kent

Both the magnitude and function of vaccine-induced HIV-specific CD8+ CTLs are likely to be important in the outcome of infection. We hypothesized that rapid cytolysis by CTLs may facilitate control of viral challenge. Release kinetics of the cytolytic effector molecules granzyme B and perforin, as well as the expression of the degranulation marker CD107a and IFN-gamma were simultaneously studie...

Journal: :Genetic Vaccines and Therapy 2007
Eduardo DC Gonçalves Vânia Luiza D Bonato Denise M da Fonseca Edson G Soares Izaíra T Brandão Ana Paula M Soares Célio L Silva

Vaccines are considered by many to be one of the most successful medical interventions against infectious diseases. But many significant obstacles remain, such as optimizing DNA vaccines for use in humans or large animals. The amount of doses, route and easiness of administration are also important points to consider in the design of new DNA vaccines. Heterologous prime-boost regimens probably ...

Journal: :Nature 2021

Abstract SARS-CoV-2 spike mRNA vaccines 1–3 mediate protection from severe disease as early ten days after prime vaccination 3 , when neutralizing antibodies are hardly detectable 4–6 . Vaccine-induced CD8 + T cells may therefore be the main mediators of at this stage 7,8 The details their induction, comparison to natural infection, and association with other arms vaccine-induced immunity remai...

2017
Georgi Shukarev Benoit Callendret Kerstin Luhn Macaya Douoguih

The consequences of the 2013-16 Ebola Zaire virus disease epidemic in West Africa were grave. The economies, healthcare systems and communities of Guinea, Sierra Leone and Liberia were devastated by over 18 months of active Ebola virus transmission, followed by sporadic resurgences potentially related to sexual transmission by survivors with viral persistence in body fluids following recovery. ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Stacie M Goldberg Shirley M Bartido Jason P Gardner José A Guevara-Patiño Stephanie C Montgomery Miguel-Angel Perales Maureen F Maughan JoAnn Dempsey Gerald P Donovan William C Olson Alan N Houghton Jedd D Wolchok

PURPOSE Immunization of mice with xenogeneic DNA encoding human tyrosinase-related proteins 1 and 2 breaks tolerance to these self-antigens and leads to tumor rejection. Viral vectors used alone or in heterologous DNA prime/viral boost combinations have shown improved responses to certain infectious diseases. The purpose of this study was to compare viral and plasmid DNA in combination vaccinat...

Journal: :Infection and immunity 2006
Michael Santosuosso Sarah McCormick Xizhong Zhang Anna Zganiacz Zhou Xing

Parenterally administered Mycobacterium bovis BCG vaccine confers only limited immune protection from pulmonary tuberculosis in humans. There is a need for developing effective boosting vaccination strategies. We examined a heterologous prime-boost regimen utilizing BCG as a prime vaccine and our recently described adenoviral vector expressing Ag85A (AdAg85A) as a boost vaccine. Since we recent...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید